Soluble neprilysin retains catalytic activity in heart failure

Journal of Heart and Lung Transplantation

Volumn 35, Issue 5, 2016, Pages 684-685

  Bayes Genis, Antoni ^a,b   Prickett, Timothy C ^c   Richards, A Mark ^c   Barallat, Jaume ^d   Lupón, Josep ^a,b  

^a Germans Trias i Pujol Foundation   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON; BRAIN NATRIURETIC PEPTIDE;

AGED; CARDIAC PATIENT; CATALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME SUBSTRATE; FEMALE; FLUOROMETRY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LETTER; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NEPRILYSIN;

EID: 84962082634     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.12.015     Document Type: Letter

References (6)

1. A. Bayes-Genis Neprilysin: from oblivion to centerstage JACC Heart Fail 3 2015 637 640
2. J.J. McMurray, M. Packer, A.S. Desai PARADIGM-HF investigators and committees Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
3. A. Bayes-Genis, J. Barallat, A. Galan, and et al. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients J Am Coll Cardiol 65 2015 657 665
4. A. Bayes-Genis, J. Barallat, D. Pascual-Figal, and et al. Prognostic value and kinetics of soluble neprilysin in acute heart failure. A pilot study JACC Heart Fail 3 2015 341 344
5. T.G. Yandle, M. Richards, M. Smith, and et al. Assay of endopeptidase-24·11 activity in plasma applied to in vivo studies of endopeptidase inhibitors Clin Chem 38 1992 1785 1791
6. N. Vodovar, M.F. Séronde, S. Laribi, and et al. Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure JACC Heart Fail 3 2015 629 636